Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network

Drug toxicity is frequently caused by electrophilic reactive metabolites that covalently bind to proteins. Epoxides comprise a large class of three-membered cyclic ethers. These molecules are electrophilic and typically highly reactive due to ring tension and polarized carbon–oxygen bonds. Epoxides are metabolites often formed by cytochromes P450 acting on aromatic or double bonds. The specific location on a molecule that undergoes epoxidation is its site of epoxidation (SOE). Identifying a molecule’s SOE can aid in interpreting adverse events related to reactive metabolites and direct modification to prevent epoxidation for safer drugs. This study utilized a database of 702 epoxidation reactions to build a model that accurately predicted sites of epoxidation. The foundation for this model was an algorithm originally designed to model sites of cytochromes P450 metabolism (called XenoSite) that was recently applied to model the intrinsic reactivity of diverse molecules with glutathione. This modeling algorithm systematically and quantitatively summarizes the knowledge from hundreds of epoxidation reactions with a deep convolution network. This network makes predictions at both an atom and molecule level. The final epoxidation model constructed with this approach identified SOEs with 94.9% area under the curve (AUC) performance and separated epoxidized and non-epoxidized molecules with 79.3% AUC. Moreover, within epoxidized molecules, the model separated aromatic or double bond SOEs from all other aromatic or double bonds with AUCs of 92.5% and 95.1%, respectively. Finally, the model separated SOEs from sites of sp2 hydroxylation with 83.2% AUC. Our model is the first of its kind and may be useful for the development of safer drugs. The epoxidation model is available at http://swami.wustl.edu/xenosite.

[1]  S. Joshua Swamidass,et al.  Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. , 2015, Chemical research in toxicology.

[2]  Pierre Baldi,et al.  Deep autoencoder neural networks for gene ontology annotation predictions , 2014, BCB.

[3]  Lars Olsen,et al.  Trends in predicted chemoselectivity of cytochrome P450 oxidation: B3LYP barrier heights for epoxidation and hydroxylation reactions. , 2014, Journal of molecular graphics & modelling.

[4]  C. Ramasamy,et al.  COMPARISION OF EFFICACY AND SAFETY OF CARBAMAZEPINE AND ESLICARBAZEPINE IN ADULT PARTIAL AND GENERALIZED SEIZURES , 2014 .

[5]  M. Pirmohamed,et al.  Covalent adduction of carbamazepine 10, 11-epoxide with human serum albumin and glutathione S-transferase pi: implications for carbamazepine hypersensitivity , 2014, The Lancet.

[6]  Sanjay Joshua Swamidass,et al.  XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural Networks , 2013, J. Chem. Inf. Model..

[7]  D. Lamb,et al.  Streptomyces cytochromes P450: applications in drug metabolism , 2013, Expert opinion on drug metabolism & toxicology.

[8]  Tara N. Sainath,et al.  Deep convolutional neural networks for LVCSR , 2013, 2013 IEEE International Conference on Acoustics, Speech and Signal Processing.

[9]  Pavel Hobza,et al.  On the performance of the semiempirical quantum mechanical PM6 and PM7 methods for noncovalent interactions , 2013 .

[10]  Paolo Benedetti,et al.  Exposition and reactivity optimization to predict sites of metabolism in chemicals. , 2013, Drug discovery today. Technologies.

[11]  Valérie Campagna-Slater,et al.  Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s , 2012, J. Chem. Inf. Model..

[12]  Alessandro Pedretti,et al.  Reactions and enzymes in the metabolism of drugs and other xenobiotics. , 2012, Drug discovery today.

[13]  Kristin P. Bennett,et al.  RS-Predictor Models Augmented with SMARTCyp Reactivities: Robust Metabolic Regioselectivity Predictions for Nine CYP Isozymes , 2012, J. Chem. Inf. Model..

[14]  F. Guengerich,et al.  Contributions of human enzymes in carcinogen metabolism. , 2012, Chemical research in toxicology.

[15]  D. Amacher The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury , 2012, Expert opinion on drug metabolism & toxicology.

[16]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[17]  A. Stepan,et al.  Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. , 2011, Chemical research in toxicology.

[18]  J. Harder,et al.  Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose , 2011, Hemodialysis international. International Symposium on Home Hemodialysis.

[19]  Ian D. Wilson,et al.  Managing the challenge of chemically reactive metabolites in drug development , 2011, Nature Reviews Drug Discovery.

[20]  B. Fromenty,et al.  Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. , 2011, Journal of hepatology.

[21]  Q. Ning,et al.  Acute liver failure: mechanisms of immune‐mediated liver injury , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[22]  S. Attia Deleterious effects of reactive metabolites , 2010, Oxidative medicine and cellular longevity.

[23]  Pierre Baldi,et al.  A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval , 2010, Bioinform..

[24]  R. El-Mallakh,et al.  Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures , 2010, Therapeutics and clinical risk management.

[25]  David E. Gloriam,et al.  SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. , 2010, ACS medicinal chemistry letters.

[26]  Q. Zeng,et al.  Cytochrome P450-mediated epoxidation of 2-aminothiazole-based AKT inhibitors: identification of novel GSH adducts and reduction of metabolic activation through structural changes guided by in silico and in vitro screening. , 2010, Chemical research in toxicology.

[27]  Dominic P. Williams,et al.  Quantifying the Metabolic Activation of Nevirapine in Patients by Integrated Applications of NMR and Mass Spectrometries , 2010, Drug Metabolism and Disposition.

[28]  R. Steenwyk,et al.  In vitro evidence for the formation of reactive intermediates of resveratrol in human liver microsomes , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[29]  Vijay T. Ahuja,et al.  Comparative Biotransformation of Pyrazinone-Containing Corticotropin-Releasing Factor Receptor-1 Antagonists: Minimizing the Reactive Metabolite Formation , 2010, Drug Metabolism and Disposition.

[30]  A. Kalgutkar,et al.  Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity? , 2009, Chemistry & biodiversity.

[31]  Yuan Chen,et al.  Revisiting the metabolism of ketoconazole using accurate mass. , 2009, Drug metabolism letters.

[32]  Chang-Joon Lee,et al.  EaMEAD: Activation Energy Prediction of Cytochrome P450 Mediated Metabolism with Effective Atomic Descriptors , 2009, J. Chem. Inf. Model..

[33]  R Scott Obach,et al.  In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam. , 2008, Chemical research in toxicology.

[34]  Chris Morley,et al.  Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit , 2008, Chemistry Central journal.

[35]  Wei Tang Drug metabolite profiling and elucidation of drug-induced hepatotoxicity , 2007, Expert opinion on drug metabolism & toxicology.

[36]  M. Kubo,et al.  Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity1 , 2007, The Journal of Immunology.

[37]  S. Amin,et al.  Investigation of the genotoxicity of dibenzo[c,p]chrysene in human carcinoma MCF-7 cells in culture. , 2006, Chemico-biological interactions.

[38]  J. Leeder,et al.  PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE , 2005, Drug Metabolism and Disposition.

[39]  N. Kaplowitz,et al.  Hepatic mitochondrial glutathione: transport and role in disease and toxicity. , 2005, Toxicology and applied pharmacology.

[40]  S. Amin,et al.  Human cytochromes P450 1A1 and 1B1 catalyze ring oxidation but not nitroreduction of environmental pollutant mononitropyrene isomers in primary cultures of human breast cells and cultured MCF-10A and MCF-7 cell lines. , 2004, Chemical research in toxicology.

[41]  Paul A. Smith,et al.  Comparison of Linear and Nonlinear Classification Algorithms for the Prediction of Drug and Chemical Metabolism by Human UDP-Glucuronosyltransferase Isoforms , 2003, J. Chem. Inf. Comput. Sci..

[42]  Gabriele Cruciani,et al.  Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. , 2003, Journal of medicinal chemistry.

[43]  Simon C Watkins,et al.  Role of glutathione conjugate efflux in cellular protection against benzo[a]pyrene‐7,8‐diol‐9,10‐epoxide–induced DNA damage , 2002, Molecular carcinogenesis.

[44]  F. Guengerich,et al.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.

[45]  M. Kalis,et al.  Oxcarbazepine, an antiepileptic agent. , 2001, Clinical therapeutics.

[46]  C J Omiecinski,et al.  Epoxide hydrolases: biochemistry and molecular biology. , 2000, Chemico-biological interactions.

[47]  S. Knowles,et al.  Idiosyncratic drug reactions: the reactive metabolite syndromes , 2000, The Lancet.

[48]  Andrew Hunter,et al.  Application of neural networks and sensitivity analysis to improved prediction of trauma survival , 2000, Comput. Methods Programs Biomed..

[49]  A. Namera,et al.  Automated preparation and analysis of barbiturates in human urine using the combined system of PrepStation and gas chromatography-mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[50]  J. Seidegård,et al.  The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. , 1997, Environmental health perspectives.

[51]  B. Hammock,et al.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase , 1997, Nature Medicine.

[52]  J. Dawson,et al.  Heme-Containing Oxygenases. , 1996, Chemical reviews.

[53]  M. Pirmohamed,et al.  Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. , 1995, Biochemical pharmacology.

[54]  J. DiMasi,et al.  Success rates for new drugs entering clinical testing in the United States , 1995, Clinical pharmacology and therapeutics.

[55]  H. Bartsch,et al.  Anti-benzo[a]pyrene diolepoxide--DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. , 1995, Carcinogenesis.

[56]  James J. P. Stewart,et al.  MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..

[57]  T. C. Bruice,et al.  Intermediates in the epoxidation of alkenes by cytochrome P-450 models. 5. Epoxidation of alkenes catalyzed by a sterically hindered (meso-tetrakis(2,6-dibromophenyl)porphinato)iron(III) chloride , 1989 .

[58]  Y. Løyning,et al.  A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy , 1989, Epilepsy Research.

[59]  J R Gillette,et al.  The role of biotransformation in chemical-induced liver injury. , 1976, Environmental health perspectives.

[60]  K. Alton,et al.  Biotransformation of a 1,5-benzodiazepine, triflubazam, by man. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[61]  W. Whalley,et al.  Metabolism of quinalbarbitone , 1975, The Journal of pharmacy and pharmacology.

[62]  N. Isaacs,et al.  Mechanisms Of Epoxide Reactions , 1959 .

[63]  C. Morisseau Role of epoxide hydrolases in lipid metabolism. , 2013, Biochimie.

[64]  Zhiwen Zhang,et al.  Investigation of piceid metabolites in rat by liquid chromatography tandem mass spectrometry. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[65]  D A Smith,et al.  Role of reactive metabolites in drug-induced hepatotoxicity. , 2010, Handbook of experimental pharmacology.

[66]  D. Galeone,et al.  Acute hepatitis in a patient treated with carbamazepine , 2004, Journal of Neurology.

[67]  F. Guengerich Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. , 2003, Archives of biochemistry and biophysics.

[68]  Michael M. Mysinger,et al.  Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction. , 2002, Drug metabolism and disposition: the biological fate of chemicals.